Lonza

Our recent webinar, "Commercial Tech Transfers in OSD Manufacturing," is now available on demand. Rebecca Peek PMP, MSBE and Laura Treche, our oral solid dosage form experts, shared key insights on executing tech transfers successfully, including: * Lonza's tech transfer process * Lonza’s equipment capabilities * How to effectively navigate operational challenges If you missed the live session, you can watch it now for free at https://lnkd.in/d-MtYpag. Please reach out to us if you'd like more details about our capabilities.  #Lonza #AdvancedSynthesis #CDMO

Diana joined Lonza in 2021, and works as a Program Management Group Leader at our site in Visp, Switzerland. Here, her work involves leading her team in managing bioconjugate customer programs and coming up with creative solutions to address organizational challenges. “I was drawn to program management because of my passion for working with people. When I first started in my career, I pictured myself sitting in the lab curing cancer all on my own, but I soon realized that achieving big goals requires a team. This eventually led me to team management, where I love making an impact by leading my group. There are so many opportunities to grow and develop or try out new roles at Lonza, but you must be willing to put in the hard work. If you see a gap, fill it. if you see a challenge, resolve it. These experiences stretch you and help you grow your career.” #Lonza #Careers #CareerGrowth Learn more about careers at Lonza: https://lnkd.in/gj8JnVy

The countdown to International Society for Cell & Gene Therapy (ISCT)'s Annual Meeting has started! You can find us at booth #714, where our experts will be on hand to share their expertise about our latest technologies and platforms for cell & gene therapy developers. Our new, chemically defined TheraPEAK® T-VIVO® T Cell Culture Medium significantly reduces the risk of viral contamination as well as the presence of adventitious agents and eliminates the need for serum addition. Come to our booth to request your exclusive and free sample* *Terms and conditions apply 📅 8 May 2025, 1:00pm - 1:15pm CDT Global Showcase presentation: "Rapid CAR-T cells: Reducing costs and enabling high-throughput production of potent memory CAR-T cell products in an automated 3-day manufacturing process” 🗣️ Speaker: Tamara J. Laskowski, PhD (Senior Director, Clinical Development) 📅 7 - 8 May 2025 – Throughout the program at ISCT "Non-viral delivery of complex cargos for large-scale T cell manufacturing" 🗣️ Presenter: Valeria Annibaldi (Manager, R&D) #celltherapy #genetherapy #ISCT2025 #specializedmodalaities

We’re excited to participate in PEGS Boston 2025, where our experts will share fresh insights into overcoming key challenges in biotherapeutic development. Join us for two impactful presentations: 🔬 Peter O'Callaghan, Senior Director, Head of Expression System Sciences, will present: "Overcoming biotherapeutic protein expression challenges with advanced vector technology". Discover how cutting-edge vector design drives higher yields and better expression of a range of therapeutic proteins. ⚗️ Andrew Dent, Associate Principal Scientist, Purification Development, will present: "Overcoming mammalian purification development challenges: balancing complexity, performance, risk, and speed across diverse molecule formats". Gain strategies for navigating the growing complexity of purification across today’s diverse biotherapeutic pipelines. We look forward to connecting with peers and collaborators across the industry as we advance the science together. Let us know if you’ll be there! #PEGSBoston #Lonza #IntegratedBiologics #PurificationDevelopment #InnovationInBiologics

Something exciting is coming! Join our expert Peter O'Callaghan, Ph.D., for a live online session as he shares a behind-the-scenes look at the development of a novel, high-strength synthetic gene promoter. Designed to boost CHOK1SV GS-KO® titers whilst delivering excellent product quality and expression stability, for a broad range of multichain therapeutic proteins. Whether you're just beginning your biologics journey or refining your current strategy, this webinar will offer insights you won’t want to miss. 📅 Date: Thursday, May 16, 2025 🕑 Time: 11:00 AM ET | 5:00 PM CET Key topics will include: ✓ Novel elements of the GS® CHO vector system coming soon ✓ Enhanced titer data with excellent quality and stability ✓ Practical applications and real-life case study 👉 Register here to reserve your spot and set your program on the right course: https://lnkd.in/dXu-azne We look forward to seeing you there! #ComingSoon #Lonza #Webinar #IntegratedBiologics #LonzaExpressionSystems #LonzaInYourLab

Last week in Rome, our VP of Sales, Specialized Modalities (Cell & Gene, mRNA and Microbial), Behnam Ahmadian Baghbaderani, had the honor of moderating the panel “Commercializing ATMPs: Moving from Innovation to Market Success” at the ARM’s 2025 Cell & Gene Meeting on the Med. The panel was joined by Rebecca Poehnelt (VP, Global Commercial Strategy, Lymphoma, Leukemia and Cell Therapy, Johnson & Johnson Innovative Medicine), Shankar Musunuri, PhD, MBA (Chairman, CEO & Co-founder, Ocugen), and Kinnari Patel, PharmD, MBA (President, Head of R&D and COO, Rocket Pharma). Together, they brought diverse perspectives from three pioneering companies—each with advanced CGT programs either already commercialized or in the path to commercialization.  Key insights from the panel: - Real-world challenges in bringing cell and gene therapies to market—especially pricing, patient access, and the evolving regulatory landscape - The critical need for robust manufacturing and supply chain infrastructure - The importance of early coordination with regulatory bodies and payer systems - Optimism for the future, with collaboration and innovation leading the way We are proud to be part of this evolving ecosystem—partnering with biotech and pharma to turn breakthrough innovations into viable therapies and manufacture the medicine of tomorrow. Thank you to the team of Alliance for Regenerative Medicine for hosting such an energizing and important gathering! #CellTherapy #GeneTherapy #CGMed25 #LonzaCGT

We’re excited to announce that the April edition of Biologics In Focus, our monthly newsletter from Lonza, is now available. In this month’s newsletter, we’re pleased to share the latest insights and innovations shaping the biologics industry, including: • How accelerating toxicology material delivery can help shorten IND timelines • Tailored downstream strategies that improve yield, purity, and stability for complex biologics • The critical role of in-use stability testing in ensuring safe and effective administration • Our latest investment in Vacaville, CA—positioning the site as one of the world’s largest biologics manufacturing facilities • Advances in expression vector optimization to enhance titer and product quality You’ll also find details about our upcoming webinar on novel GS® CHO vector technology, designed to support more efficient and scalable biomanufacturing. 🔗 Read the full edition, subscribe, and stay informed. #IntegratedBiologics #BiologicsInFocus #Biotechnology #ThePeoplePoweringBiologics

📽️ Missed our recent regulatory webinar: https://lnkd.in/d9bFNZkP? Eva María Vázquez Otero and Elizabeth Crofts from our Business Development team have a quick message for you — the recording is now available to watch on demand! Proving safety, efficacy and quality are key requirements for the various regulatory bodies around the world, but their precise requirements vary. They also differ according to the phase of development. This recent webinar by two of our regulatory experts gave a great insight into what’s needed and how we can help. Praveenkumar Devakadaksham (Director, Regulatory Affairs, CMC) and Roché Marcel Walliser (Director, Regulatory Affairs, Advanced Synthesis) explained some of the differences, and looked at how the Lonza Advanced Synthesis team is able to assist in ensuring all filings are right first time. If you missed it live, the webinar is now available to watch on demand: https://lnkd.in/d9bFNZkP. #Lonza #AdvancedSynthesis #LonzaRegulatoryWebinar #CDMO

We are excited to attend RDD Europe 2025 this year in Estoril, Portugal from 6 - 9 May. Stop by our booth at the "Inspiring Dry Powder Inhalation Knowledge Space", and join us for a series of insightful presentations from our experts: * Workshop Session: 📅 7 May 2025, 2:00pm - 5:30pm CEST Title: “An expanded toolbox for respirable dry powders: pulmonary and intranasal delivery for small and biotherapeutic APIs” Speakers: Beatriz Noriega Fernandes, PhD (Principal Investigator, Manager CMC) and Eric Peterson, PhD (Senior Scientist, Product Development) * Poster Presentations: 📅 7 - 9 May 2025 Title: “Spray-dried lipid nanoparticles for intranasal delivery” Poster presenter: Cameron Kadleck (Lead Scientist, Research & Development) 📅 7 - 9 May 2025 Title: “Fine-tuning spray-dried inhalable powders: impact of component saturation on performance” Poster presenter: Emily Osborne (Scientist, Product Development) The Lonza team looks forward to connecting with you at RDD Europe 2025!   #Lonza #AdvancedSynthesis #CDMO #RDDEurope2025

In celebration of Earth Day, we’re proud to share the meaningful steps we’ve taken to reduce our environmental impact and reaffirm our commitment to sustainable operations as a critical component of our One Lonza strategy. In 2024, we continued to make progress on our journey towards achieving our sustainability goals. The Science Based Targets initiative validated our near-term GHG emission reduction targets, including our commitment to reducing absolute Scope 1 and 2 GHG emissions by 42% by 2030, from a 2021 base year. We also increased the proportion of renewable energy in support of our ambition to purchase 100% of electricity from renewable sources by 2025, where available. Half of our electricity production is already procured from renewable sources, supported by renewable power agreements in the EU and China, and we have worked to increase this further with agreements in the US. Read more about our ambitions and progress in our Sustainability Report 2024: https://lnkd.in/dyJ_Xdcc #Lonza #EarthDay #Sustainability #Renewables #SBTi